Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington shared a post by Albert Jang, Internal Medicine Resident at Tulane University School of Medicine on X, adding:
“Congrats Albert Jang, Jason Brown, Vadim Koshkin, Tanya Jindal and team: excellent work on UNITE registry asking practical important questions in “real world setting” happy to be part of this.”
Quoting Albert Jang‘s post:
“Excited to share our work, as we now move EV+P to the MIBC space GU26 Appreciate the mentorship from Jason Brown, Vadim Koshkin in collab with.”
Title: Real-World Outcomes of Patients With Baseline Neuropathy and/or Diabetes Mellitus Receiving Enfortumab Vedotin-Based Regimens for Advanced Urothelial Carcinoma in the UNITE Database
Authors: Albert Jang, Tanya Jindal, Ali Raza Khaki, Cindy Y. Jiang, Omar Alhalabi, Charles B. Nguyen, Irene Tsung, Eugene Oh, Ilana Epstein, Dimitra Rafailia Bakaloudi, Salvador Jaime-Casas, Amanda Nizam, Michael Glover, Hannah Mabey, Amy Taylor, Sean Evans, Denny Shin, Cameron Pywell, Bashar Abuqayas, Pedro C. Barata, Yousef Zakharia, Arnab Basu, Deepak Kilari, Mehmet A. Bilen, Hamid Emamekhoo, Matthew Milowsky, Christopher J. Hoimes, Nancy Davis, Sumit Shah, Shilpa Gupta, Abishek Tripathi, Petros Grivas, Joaquim Bellmunt, Ajjai Alva, Matthew T. Campbell, Zhengyi Chen, Pingfu Fu, Vadim S. Koshkin, Jason R. Brown
Read The Full Article
More posts featuring Petros Grivas on OncoDaily.